These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 27354115

  • 1. CD101: a novel long-acting echinocandin.
    Zhao Y, Perez WB, Jiménez-Ortigosa C, Hough G, Locke JB, Ong V, Bartizal K, Perlin DS.
    Cell Microbiol; 2016 Sep; 18(9):1308-16. PubMed ID: 27354115
    [Abstract] [Full Text] [Related]

  • 2. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA, Messer SA, Rhomberg PR, Castanheira M.
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [Abstract] [Full Text] [Related]

  • 3. Structure-Activity Relationships of a Series of Echinocandins and the Discovery of CD101, a Highly Stable and Soluble Echinocandin with Distinctive Pharmacokinetic Properties.
    James KD, Laudeman CP, Malkar NB, Krishnan R, Polowy K.
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27919891
    [Abstract] [Full Text] [Related]

  • 4. Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.
    Pfaller MA, Messer SA, Rhomberg PR, Jones RN, Castanheira M.
    J Antimicrob Chemother; 2016 Oct; 71(10):2868-73. PubMed ID: 27287236
    [Abstract] [Full Text] [Related]

  • 5. Characterization of In Vitro Resistance Development to the Novel Echinocandin CD101 in Candida Species.
    Locke JB, Almaguer AL, Zuill DE, Bartizal K.
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6100-7. PubMed ID: 27480852
    [Abstract] [Full Text] [Related]

  • 6. Pharmacodynamics of a Long-Acting Echinocandin, CD101, in a Neutropenic Invasive-Candidiasis Murine Model Using an Extended-Interval Dosing Design.
    Lepak AJ, Zhao M, VanScoy B, Ambrose PG, Andes DR.
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203480
    [Abstract] [Full Text] [Related]

  • 7. In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis.
    Boikov DA, Locke JB, James KD, Bartizal K, Sobel JD.
    J Antimicrob Chemother; 2017 May 01; 72(5):1355-1358. PubMed ID: 28158577
    [Abstract] [Full Text] [Related]

  • 8. Accuracy of Sensititre YeastOne echinocandins epidemiological cut-off values for identification of FKS mutant Candida albicans and Candida glabrata: a ten year national survey of the Fungal Infection Network of Switzerland (FUNGINOS).
    Kritikos A, Neofytos D, Khanna N, Schreiber PW, Boggian K, Bille J, Schrenzel J, Mühlethaler K, Zbinden R, Bruderer T, Goldenberger D, Pfyffer G, Conen A, Van Delden C, Zimmerli S, Sanglard D, Bachmann D, Marchetti O, Lamoth F, Fungal Infection Network of Switzerland (FUNGINOS).
    Clin Microbiol Infect; 2018 Nov 01; 24(11):1214.e1-1214.e4. PubMed ID: 29909005
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CD101, a Novel Echinocandin, Possesses Potent Antibiofilm Activity against Early and Mature Candida albicans Biofilms.
    Chandra J, Ghannoum MA.
    Antimicrob Agents Chemother; 2018 Feb 01; 62(2):. PubMed ID: 29133552
    [Abstract] [Full Text] [Related]

  • 14. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC.
    Dan Med J; 2013 Nov 01; 60(11):B4698. PubMed ID: 24192246
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Biofilm Production and Antibiofilm Activity of Echinocandins and Liposomal Amphotericin B in Echinocandin-Resistant Yeast Species.
    Marcos-Zambrano LJ, Gómez-Perosanz M, Escribano P, Zaragoza O, Bouza E, Guinea J.
    Antimicrob Agents Chemother; 2016 Jun 01; 60(6):3579-86. PubMed ID: 27021323
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
    Kordalewska M, Lee A, Park S, Berrio I, Chowdhary A, Zhao Y, Perlin DS.
    Antimicrob Agents Chemother; 2018 Jun 01; 62(6):. PubMed ID: 29632013
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological Basis of CD101 Efficacy: Exposure Shape Matters.
    Lakota EA, Bader JC, Ong V, Bartizal K, Miesel L, Andes DR, Bhavnani SM, Rubino CM, Ambrose PG, Lepak AJ.
    Antimicrob Agents Chemother; 2017 Nov 01; 61(11):. PubMed ID: 28848022
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.